Search research articles
Contact Us
Filters
Showing results (41-50 of 112) with videos related to
Page
of 12
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
July 1, 2010
A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model
Yong Zhang, Jinhui Zhang, Lei Wang, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2009
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
Ashraf H Abadi, Tamer M Ibrahim, Khaled M Abouzid, et al.
Molecular Cancer Therapeutics
|
December 10, 2009
Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G
Heather N Tinsley, Bernard D Gary, Adam B Keeton, et al.
Journal of Biomedical Research
|
March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
Jason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Scientia Pharmaceutica
|
January 25, 2017
Structure-Based Design of Novel Tetrahydro-Beta-Carboline Derivatives with a Hydrophilic Side Chain as Potential Phosphodiesterase Inhibitors
Ahmed K Elhady, Sara C Sigler, Nazih Noureldin, et al.
The Journal of Pharmacy and Pharmacology
|
October 30, 2008
Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate
Lee Jia, Patricia E Noker, Gary A Piazza, et al.
Archiv Der Pharmazie
|
January 12, 2013
Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors
Dalia S El-Gamil, Nermin S Ahmed, Bernard D Gary, et al.
Chemmedchem
|
July 13, 2013
6-Aryl and heterocycle quinazoline derivatives as potent EGFR inhibitors with improved activity toward gefitinib-sensitive and -resistant tumor cell lines
Mostafa M Hamed, Dalal A Abou El Ella, Adam B Keeton, et al.
Trends in Molecular Medicine
|
May 5, 2026
Targeting the NAD<sup>+</sup>-PARP1-XRCC1 axis in ALS
Md Ibrahim, Md Shahadat Hossain, Lezanne Ooi, et al.
Pharmaceutics
|
November 27, 2025
Novel Disulfiram-Loaded Metal-Organic Nanoparticles Inhibit Tumor Growth and Induce Immunogenic Cell Death of Triple-Negative Breast Cancer Cells
Chung-Hui Huang, Xuejia Kang, Lang Zhou, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 112) with videos related to
Sort By:
Page
of 12
Cancer Prevention Research (Philadelphia, Pa.)
|
July 1, 2010
A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model
Yong Zhang, Jinhui Zhang, Lei Wang, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2009
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
Ashraf H Abadi, Tamer M Ibrahim, Khaled M Abouzid, et al.
Molecular Cancer Therapeutics
|
December 10, 2009
Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G
Heather N Tinsley, Bernard D Gary, Adam B Keeton, et al.
Journal of Biomedical Research
|
March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
Jason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Scientia Pharmaceutica
|
January 25, 2017
Structure-Based Design of Novel Tetrahydro-Beta-Carboline Derivatives with a Hydrophilic Side Chain as Potential Phosphodiesterase Inhibitors
Ahmed K Elhady, Sara C Sigler, Nazih Noureldin, et al.
The Journal of Pharmacy and Pharmacology
|
October 30, 2008
Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate
Lee Jia, Patricia E Noker, Gary A Piazza, et al.
Archiv Der Pharmazie
|
January 12, 2013
Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors
Dalia S El-Gamil, Nermin S Ahmed, Bernard D Gary, et al.
Chemmedchem
|
July 13, 2013
6-Aryl and heterocycle quinazoline derivatives as potent EGFR inhibitors with improved activity toward gefitinib-sensitive and -resistant tumor cell lines
Mostafa M Hamed, Dalal A Abou El Ella, Adam B Keeton, et al.
Trends in Molecular Medicine
|
May 5, 2026
Targeting the NAD<sup>+</sup>-PARP1-XRCC1 axis in ALS
Md Ibrahim, Md Shahadat Hossain, Lezanne Ooi, et al.
Pharmaceutics
|
November 27, 2025
Novel Disulfiram-Loaded Metal-Organic Nanoparticles Inhibit Tumor Growth and Induce Immunogenic Cell Death of Triple-Negative Breast Cancer Cells
Chung-Hui Huang, Xuejia Kang, Lang Zhou, et al.
Page
of 12